Insider · CIK 0001651572
Deina H Walsh
Files at BBLG (Bone Biologics Corp). First filing -, latest -.
In brief
Deina H Walsh files SEC Form 4 as CFO at BBLG (Bone Biologics Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Deina H Walsh has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | BBLG Bone Biologics Corp | AGrant or award Employee Stock Optionderivative | +8,335 | $0.00 | $0 | 8,335 | Jan 21, 2026 |
| Jan 15, 2025 | BBLG Bone Biologics Corp | AGrant or award Employee Stock Optionderivative | +27,055 | $0.00 | $0 | 27,055 | Jan 21, 2025 |
Questions about Deina H Walsh
Answered from the filings on this page, as of the latest one.
Is Deina H Walsh buying or selling?
Deina H Walsh has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Deina H Walsh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Deina H Walsh has 0.
Where does Deina H Walsh file Form 4?
Deina H Walsh has filed Form 4 at BBLG (Bone Biologics Corp) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.